the Brazil National Team. The fourth 3-pointer ignited the Iowa City crowd as Clark unleashed the shot from beyond the logo − 36 feet away from the hoop. The former Hawkeyes star celebrated near the ...

Last year at WrestleMania 40, Seth Rollins was Cody Rhodes' Shield, protecting him from Roman Reigns and the OG Bloodline. The American Nightmare could play the same role for Randy Orton this ...

In a Monday note, Morgan Stanley equity strategist Mike Wilson broke down where investors should rotate their investments to better shield themselves ... Wilson said. 3. Buy industrials over ...

The undisputed super middleweight title will be on the line when Canelo Alvarez takes on William Scull in a 12-round bout on Saturday. The Canelo vs. Scull fight card at ANB Arena in Riyadh ...

Caitlin Clark gave her Iowa hometown fans exactly what they wanted Sunday afternoon: logo 3-pointers and an exciting return ...

The highly-anticipated seven episodes debuted to 68 million views in their first week, ending with a mighty cliffhanger that makes Season 3 feel more like Season 2, Part 2. Three years after the ...

The fans packed Carver-Hawkeye Arena on the University of Iowa campus Sunday to watch Caitlin Clark return to the school where she set plenty of college records. Her Indiana Fever team played an ...

With a Big Ten regular-season title on the line in 2022 ... Clark scored on a sweet slide-step 3-pointer 32 seconds into the Indiana Fever’s May 4 exhibition game – from just inside the tip of logo ...

With a Big Ten regular-season title on the line in 2022 ... slide-step 3-pointer 32 seconds into the Indiana Fever’s May 4 exhibition game – from just inside the tip of logo Herky’s beak ...

Inter ended up winning the game 4-3, much of the drama coming during the ... Scoring six goals is nothing to scoff at but Barcelona's porous back line finally cost them, denying them a chance ...

Malaysia 3 Year Government Bond-0.0720 3.2800% ...

MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two ...